DOCSLIB.ORG

Dermatology for the Advanced Practice Nurse

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Dermatology for the Advanced Practice Nurse o Lyons us L Dermatology for the ey AdvanceD Practice nurse the for Dermatology Dermatology Faye Lyons, DNP, RN, FNP-C & Lisa ousley, DNP, RN, FNP-C Unique decision trees promote accurate diagnosis and treatment of 60 common skin conditions for the his is the first primary care dermatology reference written by and for nurses. It focuses on approximately 60 skin conditions that are commonly seen in primary care settings and Tprovides unique decision trees to assist in accurate diagnosis. Organized for quick access, the AdvanceD book presents conditions alphabetically and includes evidence-based treatment and management strategies along with full-color photos taken during actual office visits. Dermatologic diagnostics cover skin assessment, specimen collection procedures, and use of mechanical devices, along with relevant evidence-based topical, systemic, and surgical treatment options. Ad Practice nurse The resource provides an overview of dermatology basics including skin anatomy and physi- ology and skin terminology. Illustrations, graphs, and skin terminology help to accurately document descriptions of rashes, lesions, and diseases during diagnostic evaluations. The book also defines vance risk factors in relation to skin conditions and diseases and delineates conditions common to specif- ic populations. A broad range of management strategies is presented along with alerts for when expert follow-up is indicated. To promote rapid identification of skin conditions, each is presented in a consistent format that includes overview, epidemiology, pathology/histology, clinical presen- D tation, differential diagnosis, treatment/management, special considerations and appropriate Practice referrals, and patient education. The Clinical Pearls feature captures the authors’ expertise. Addi- tional photos are available from the website as a digital image bank. Key Features: • Focuses on approximately 60 common dermatological conditions with high-quality, full-color photos n • Presents four unique decision trees to foster accurate diagnosis and clinical decision making urse • Delivers evidence-based protocols for diagnosis, treatment, and management • Uses a consistent format to promote quick access to information • Written by advanced-degree nurse practitioners with nurses’ informational needs in mind ISBN 978-0-8261-3643-5 Faye Lyons & Lisa ousLey 11 W. 42nd Street New York, NY 10036-8002 www.springerpub.com 9 780826 136435 Dermatology for the Advanced Practice Nurse Faye Lyons, DNP, RN, FNP-C, is a doctor of nursing practice–prepared family nurse practitioner who has been practicing in family medicine, internal medicine, derma- tology, and aesthetic dermatology since 1999. Prior to becoming an NP, Dr. Lyons was a member of the armed services (U.S. Air Force), and an RN in medical, cardiac, and surgical intensive care units and dialysis units. Her experience in dermatology includes working in two large dermatology practices during her NP career and serv- ing rural areas with dermatological services while working in internal medicine. Her responsibilities included skin examinations, biopsies, surgical excisions, and cosmetic procedures that included Botox, cosmetic fillers, and laser therapies. Dr. Lyons is cre- dentialed in dermatology nursing by the Dermatology Nursing Association. Her pub- lications include an award-winning poster presentation on dermatology decision trees at the 2012 Virginia Nurse Practioner Association meeting, dermatological chapters in an upcoming geriatric textbook titled Healthy Aging: Principles and Clinical Practice for Clinicians and in Solving a Skin Rash in Primary Care: Use of a Diagnostic Decision Tree in the journal Advance for NPs and PAs. Lisa Ousley, DNP, RN, FNP-C, is a doctor of nursing practice–prepared family nurse practitioner who has been a primary care provider since 1999. Within primary care, Dr. Ousley has assessed, treated, and referred thousands of skin conditions. Dr. Ousley has been taking photos of skin conditions for many years and has a collection of over 1,000 photos, many of which are used in this book. Dr. Ousley is the director of Eastern Tennessee State University (ETSU) Student/University Health Services. This clinical opportunity supports health promotion and clinical management of acute and episodic illness for a culturally diverse university population. Dr. Ousley’s past primary care experiences include Hillsville and Galax Family Care, outpatient hospital-based clinics in Virginia, and she has worked as a hospitalist service provider at Twin County Regional Hospital and in a clinic targeting the public-housing population in Johnson City, Tennessee. Since 2009, Dr. Ousley has been an online graduate instructor at the University of Phoenix, teaching graduate nursing theory. Dermatology for the Advanced Practice Nurse Faye Lyons, DNP, RN, FNP-C Lisa Ousley, DNP, RN, FNP-C Copyright © 2015 Springer Publishing Company, LLC All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without the prior permission of Springer Publishing Company, LLC, or authorization through payment of the appropriate fees to the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923, 978-750-8400, fax 978-646-8600, [email protected] or on the Web at www.copyright.com. Springer Publishing Company, LLC 11 West 42nd Street New York, NY 10036 www.springerpub.com Acquisitions Editor: Margaret Zuccarini Composition: diacriTech ISBN: 978-0-8261-3643-5 e-book ISBN: 978-0-8261-3644-2 Digital image bank ISBN: 978-0-8261-2825-6 A digital image bank can be accessed at www.springerpub.com/lyons-image-bank 14 15 16 17 / 5 4 3 2 1 The author and the publisher of this Work have made every effort to use sources believed to be reliable to provide information that is accurate and compatible with the standards generally accepted at the time of publication. Because medical science is continually advancing, our knowledge base continues to expand. Therefore, as new information becomes available, changes in procedures become necessary. We recommend that the reader always consult current research and specific institutional policies before performing any clinical procedure. The author and publisher shall not be liable for any special, consequential, or exemplary damages resulting, in whole or in part, from the readers’ use of, or reliance on, the information contained in this book. The publisher has no responsibility for the persistence or accuracy of URLs for external or third-party Internet websites referred to in this publication and does not guarantee that any content on such websites is, or will remain, accurate or appropriate. Library of Congress Cataloging-in-Publication Data Lyons, Faye, author. Dermatology for the advanced practice nurse / authors, Faye Lyons, Lisa Ousley. p. ; cm. Includes bibliographical references and index. ISBN 978-0-8261-3643-5—ISBN 978-0-8261-3644-2 (e-Book) I. Ousley, Lisa Ellen, author. II. Title. [DNLM: 1. Skin Diseases—nursing. 2. Nursing Diagnosis—methods. 3. Primary Nursing—methods. 4. Skin Care—nursing. WY 154.5] RL125 616.5’0231—dc23 2014008527 Special discounts on bulk quantities of our books are available to corporations, professional associations, pharmaceutical companies, health care organizations, and other qualifying groups. If you are interested in a custom book, including chapters from more than one of our titles, we can provide that service as well. For details, please contact: Special Sales Department, Springer Publishing Company, LLC 11 West 42nd Street, 15th Floor, New York, NY 10036-8002 Phone: 877-687-7476 or 212-431-4370; Fax: 212-941-7842 E-mail: [email protected] Printed in the United States of America by Bang Printing. Contents Preface ix Acknowledgments xi Share Dermatology for the Advanced Practice Nurse Part I. Overview of Dermatology 1. Education: Nurses and Primary Care Providers 3 Epidemiology and Statistics of Skin Disorders 4 Annual Economic Burden 5 Quality-of-Life Implications 5 Evidence-Based Practice and Decision Trees 6 Conceptual Framework for Assessing, Diagnosing, and Treating Skin Rashes 6 Decision Trees and Differential Diagnoses 8 2. Basics of Dermatology 15 Skin Anatomy and Physiology 15 Skin Terminology 19 Vascular Lesions 21 Diagnostic Evaluations 21 Distribution, Type, Characteristics, and Pattern of Lesions 22 Special Distribution Category: Patterns of Intentional or Unintentional Injury 22 3. Special Considerations for Populations, Culture, and Comorbid ­Conditions 27 Infants and Children 27 The Elderly 27 Ethnicity 28 Cultural Practices 28 Puberty 29 Pregnancy 29 VI ■ CONTENTS Part II. Clinical Management of Dermatology Conditions 4. Skin Assessment 35 History 35 Skin Assessment (Physical) 35 Social History 36 Family History 36 Dermatologic Signs 36 Differential Diagnosis 37 5. Diagnostics 39 Collecting Specimens 39 Mycology: Microscopic Examination of Scale (Potassium Hydroxide) 40 Use of Mechanical Devices 41 6. Treatment Approaches 43 Topical Treatment 43 Systemic Evaluation and Treatment 45 Surgical Treatment 46 Other Treatments 46 7. Clinical Management 51 Routine Skin Care 51 Preventive Care 52 Skin Self-Examination 52 Protection From the Sun 53 Moisturizer 54 Nutritional Counseling 55 Appropriate Referrals 56 Genetic Counseling Referrals 58 Part III. Common Dermatologic Conditions Abrasions and Skin Tears 61 Acne 65 Alopecia 71 Aphthous Stomatitis 79 Bruise and
Load more

Recommended publications
  • Another Rashmanaging ? Common Skin Problems in Primary Care: Ugh….Another Rash Kathleen Haycraft, DNP, FNP/PNP-BC, DCNP, FAANP Objectives
    Another RashManaging ? Common Skin Problems in Primary Care: Ugh….Another Rash Kathleen Haycraft, DNP, FNP/PNP-BC, DCNP, FAANP Objectives At the completion of this session the learner will be able to: 1. Identify common skin rashes seen in dermatology 2. Differentiate between rashes that require urgent treatment and those that require monitored therapy. 3. Determine an appropriate treatment plan for common rashes Financial Disclosures and COI The speaker is on the advisory committee for: ABVIE CELGENE LILLY NOVARTIS PFIZER VALEANT Significance Dermatologic conditions are the number one reason to enter ambulatory walk in clinics The skin it the largest organ of the body and frequently is a measure of what is occurring internally Take a good history Duration What did it look like in the beginning and how has it progressed? Does anyone else in your immediate family or workers have a similar rash? Have you been ill and in what way? What have you treated the rash with prescription or over the counter medications? Take a good history Have they seen anyone and what diagnosis where you given? What is your medical history? What medicines do you take? Does it itch, hurt, scale, or asymptomatic? Give it a scale. How did it begin and what does has it changed (tie this into treatment history)? Is the patient sick? What does it looks like? Macule vs. Patch Papule, nodule, pustule, tumor Vesicle or Bulla Petechial or purpura Indurated vs. non-indurated Is it crusted…deep or superficial What pattern…. Blaschkos vs. dermatome,, symmetrical, central vs. caudal, reticular, annular vs.
    [Show full text]
  • Familial Hyperinsulinism Due to HNF4A Deficiency and Benign Premature Adrenarche: a Case Report
    Case Report Familial Hyperinsulinism due to HNF4A Deficiency and Benign Premature Adrenarche: A Case Report Edward Compton,1 David H. Geller,2 Alaina P. Vidmar MD.3 Abstract Background: Familial Hyperinsulinism due to HNF4A deficiency (FHI-HNF4A) is a form of diazoxide-sensitive, diffuse hyperinsulinism, characterized by transient or persistent hyperinsulinemic hypoglycemia, and a propensity to develop Maturity-Onset Diabetes of the Young type 1 (MODY1). The association between FHI-HNF4A deficiency and benign premature adrenarche (BPA) is unknown. The Case: We report the case of a 5-year-old girl with FHI-HNF4A, controlled on diazoxide, who presented with BPA and Tanner stage 3 pubic hair associated with body odor and acne. Work-up revealed elevated dehydroepiandrosterone sulfate (DHEAS), elevated free testosterone, and advanced bone age. Insulin levels were elevated in the setting of normal fasting blood glucose. We discuss the possible hormonal underpinnings of hyperandrogenism. Conclusion: Though the underlying pathophysiology of this phenotype is unclear, a possible synergistic mechanism exists between insulin-induced hyperandrogenism and HNF4A deficiency leading to a transient decrease of SHBG and thus increased free testosterone levels. Further investigation is required to determine the association between HNF4A dysfunction and BPA. Key Words: Hyperinsulinism; Congenital Hyperinsulinism; Adrenarche; HNF4A; Hyperandrogenism (Source: MeSH-NLM). Introduction Congenital hyperinsulinism (CHI) is due to a variety of etiologies that Highlights: result in dysregulated insulin release from pancreatic β-cells. There are Familial Hyperinsulinism due to HNF4A deficiency (FHI-HNF4A) is a two histological variants of CHI, focal and diffuse, which differ in the form of diazoxide-sensitive; diffuse hyperinsulinism, characterized by extent of pancreatic involvement.
    [Show full text]
  • Multiple Asymptomatic Papules on the Back of the Right Side of the Chest Angoori Gnaneshwar Rao
    QUIZ Multiple Asymptomatic Papules on the Back of the Right Side of the Chest Angoori Gnaneshwar Rao A 43-year-old male presented with multiple asymptomatic complete blood picture, blood sugar, complete urine examination, papules on the back of the right side of the chest of 1 year blood urea, serum creatinine, liver function tests and serum duration. He was asymptomatic a year back then he developed lipid profile were normal. Fundus was normal. A slit skin smear small papules on the right side of the front of the chest initially for acid fast bacilli was negative. A punch biopsy from the and later on involved the front and back of the chest. No representative lesion subjected to histopathological examination history was suggestive of leprosy and hyperlipidemias. Family revealed a cyst with an intricately folded wall, lined by two to history was negative for similar problem. Examination revealed three layers of flattened squamous epithelium and the absence multiple skin-colored to yellowish papules distributed on the of the granular layer. Lobules of sebaceous glands were found front and back of the chest and shoulder region on the right embedded in cyst lining. The lumen was filled with amorphous side [Figure 1]. Also, there were multiple hyperpigmented eosinophilic material and multiple hair shafts [Figures 2-4]. macules on the right infrascapular region. There was no nerve thickening and no sensory deficit and there were no Question hypopigmented or anesthetic patches. Systemic examination did not reveal any abnormality. Routine investigations including What is your diagnosis? (Original) Multiple skin-colored to yellowish papules on the back of chest Figure 1: Figure 2: (Original) Histopathology of skin showing a cyst with an intricately folded and shoulder region on the right side wall lined by two to three layers of flattened squamous epithelium and the absence of granular layer.
    [Show full text]
  • (ERYTHEMA NODOSUM LEPROSUM) the Term
    ? THE HISTOPATHOLOGY OF ACUTE PANNICULITIS NODOSA LEPROSA (ERYTHEMA NODOSUM LEPROSUM) w. J. PEPLER, M.B., Ch.B. Department of Pathology, South African Institute for Medical Research, Johannesburg R. KOOIJ, M.D. Westfort Institution, Pretoria AND J. MARSHALL, M.D. University of Pretoria, Pretoria The term "erythema nodosum leprosum" has frequently appeared in the literature on leprosy since the 1930's, apparently popularized by the Japanese (9). The occurrence of "erythema nodosum" in leprosy had previously been noted at the end of the nineteenth century by Brocq (6) and by Hansen and Looft (8), but the term seems to have fallen into disuse. As will become clear from our clinical and histological descriptions of the phenomenon commonly known as erythema nodosum leprosum, we believe the title to be a misnomer. We suggest that it would be more accurate to call it panniculitis nodosa leprosa (P.N.L,). This condition is commonly confused with acute lepra reaction, both processes being referred to as "acute reactions"; but a sharp line of distinction must be drawn between them. P.N.L. occurs only in patients with lepromatous leprosy as an acute, subacute or chronic skin eruption, with or without fever. It is characterized by showers of dusky red nodules, 0.5 to 2 cm. in diameter, on the extensor surfaces of the limbs, on the face, and, less often, on the trunk. The number of lesions appearing in an attack varies from a few to several hundreds, and they sometimes coalesce to form plaques. The nodules may be painful, and they are usually tender to touch.
    [Show full text]
  • Chapter 3 Bacterial and Viral Infections
    GBB03 10/4/06 12:20 PM Page 19 Chapter 3 Bacterial and viral infections A mighty creature is the germ gain entry into the skin via minor abrasions, or fis- Though smaller than the pachyderm sures between the toes associated with tinea pedis, His customary dwelling place and leg ulcers provide a portal of entry in many Is deep within the human race cases. A frequent predisposing factor is oedema of His childish pride he often pleases the legs, and cellulitis is a common condition in By giving people strange diseases elderly people, who often suffer from leg oedema Do you, my poppet, feel infirm? of cardiac, venous or lymphatic origin. You probably contain a germ The affected area becomes red, hot and swollen (Ogden Nash, The Germ) (Fig. 3.1), and blister formation and areas of skin necrosis may occur. The patient is pyrexial and feels unwell. Rigors may occur and, in elderly Bacterial infections people, a toxic confusional state. In presumed streptococcal cellulitis, penicillin is Streptococcal infection the treatment of choice, initially given as ben- zylpenicillin intravenously. If the leg is affected, Cellulitis bed rest is an important aspect of treatment. Where Cellulitis is a bacterial infection of subcutaneous there is extensive tissue necrosis, surgical debride- tissues that, in immunologically normal individu- ment may be necessary. als, is usually caused by Streptococcus pyogenes. A particularly severe, deep form of cellulitis, in- ‘Erysipelas’ is a term applied to superficial volving fascia and muscles, is known as ‘necrotiz- streptococcal cellulitis that has a well-demarcated ing fasciitis’. This disorder achieved notoriety a few edge.
    [Show full text]
  • Comparison of Efficacy of Combination of 2% Ketoconazole
    Open Access Original Article Comparison of Topical Treatments in Pityriasis Versicolor Pak Armed Forces Med J 2018; 68 (6): 1725-30 COMPARISON OF EFFICACY OF COMBINATION OF 2% KETOCONAZOLE SOLUTION WASH AND TOPICAL 1% CLOTRIMAZOLE WITH TOPICAL 1% CLOTRIMAZOLE ALONE IN CASES OF PITYRIASIS VERSICOLOR Ayesha Anwar, Naeem Raza, Najia Ahmed, Hyder Ali Awan* Pak Emirates Military Hospital/National University of Medical Sciences (NUMS) Rawalpindi Pakistan, *King Abdul Aziz Naval Base, Jubail, Saudia Arabia ABSTRACT Objective: Comparison of efficacy of combination comprising 2% ketoconazole solution wash plus topical 1% clotrimazole versus topical 1% clotrimazole alone in management of patients with Pityriasis versicolor. Study Design: Randomized controlled trial. Place and Duration of Study: Dermatology department, Pak Emirates Military Hospital Rawalpindi, from Oct 2016 to Apr 2017. Material and Methods: Sixty patients of Pityriasis versicolor, both male and female were included in study. Diagnosis of Pityriasis versicolor was made clinically and confirmed microscopically by examining skin scrapings for fungal hyphae. Patients with concomitant systemic illnesses or those who had received anti-fungal in last three months were excluded from study. Random number tables were used to allocate patients to the two treatment groups. Group A received 2% ketoconazole shampoo twice per week for four weeks plus topical 1% clotrimazole twice daily application for 2 weeks. Group B received only topical therapy with 1% clotrimazole cream applied twice daily for 2 weeks. Assessment of treatment efficacy was done by clinical examination of patient and microscopy of skin scrapping for fungal hyphaedone at baseline and at end of study (4 weeks of treatment). A negative clinical examination and negative skin scrapping for fungal hyphae was considered effective therapeutic response.
    [Show full text]
  • The Management of Common Skin Conditions in General Practice
    Management of Common Skin Conditions In General Practice including the “red rash made easy” © Arroll, Fishman & Oakley, Department of General Practice and Primary Health Care University of Auckland, Tamaki Campus Reviewed by Hon A/Prof Amanda Oakley - 2019 http://www.dermnetnz.org Management of Common Skin Conditions In General Practice Contents Page Derm Map 3 Classic location: infants & children 4 Classic location: adults 5 Dermatology terminology 6 Common red rashes 7 Other common skin conditions 12 Common viral infections 14 Common bacterial infections 16 Common fungal infections 17 Arthropods 19 Eczema/dermatitis 20 Benign skin lesions 23 Skin cancers 26 Emergency dermatology 28 Clinical diagnosis of melanoma 31 Principles of diagnosis and treatment 32 Principles of treatment of eczema 33 Treatment sequence for psoriasis 34 Topical corticosteroids 35 Combination topical steroid + antimicrobial 36 Safety with topical corticosteroids 36 Emollients 37 Antipruritics 38 For further information, refer to: http://www.dermnetnz.org And http://www.derm-master.com 2 © Arroll, Fishman & Oakley, Department of General Practice and Primary Health Care, University of Auckland, Tamaki Campus. Management of Common Skin Conditions In General Practice DERM MAP Start Is the patient sick ? Yes Rash could be an infection or a drug eruption? No Insect Bites – Crop of grouped papules with a central blister or scab. Is the patient in pain or the rash Yes Infection: cellulitis / erysipelas, impetigo, boil is swelling, oozing or crusting? / folliculitis, herpes simplex / zoster. Urticaria – Smooth skin surface with weals that evolve in minutes to hours. No Is the rash in a classic location? Yes See our classic location chart .
    [Show full text]
  • Autoinvolutive Photoexacerbated Tinea Corporis Mimicking a Subacute Cutaneous Lupus Erythematosus
    Letters to the Editor 141 low-potency steroids had no eŒect. Our patient was treated 4. Jarrat M, Ramsdell W. Infantile acropustulosis. Arch Dermatol with a modern glucocorticoid which has an improved risk– 1979; 115: 834–836. bene t ratio. The antipruritic and anti-in ammatory properties 5. Kahn G, Rywlin AM. Acropustulosis of infancy. Arch Dermatol of the steroid were increased by applying it in combination 1979; 115: 831–833. 6. Newton JA, Salisbury J, Marsden A, McGibbon DH. with a wet-wrap technique, which has already been shown to Acropustulosis of infancy. Br J Dermatol 1986; 115: 735–739. be extremely helpful in cases of acute exacerbations of atopic 7. Mancini AJ, Frieden IJ, Praller AS. Infantile acropustulosis eczema in combination with (3) or even without topical revisited: history of scabies and response to topical corticosteroids. steroids (8). Pediatr Dermatol 1998; 15: 337–341. 8. Abeck D, Brockow K, Mempel M, Fesq H, Ring J. Treatment of acute exacerbated atopic eczema with emollient-antiseptic prepara- tions using ‘‘wet-wrap’’ (‘‘wet-pyjama’’) technique. Hautarzt 1999; REFERENCES 50: 418–421. 1. Vignon-Pennam en M-D, Wallach D. Infantile acropustulosis. Arch Dermatol 1986; 122: 1155–1160. Accepted November 24, 2000. 2. Duvanel T, Harms M. Infantile Akropustulose. Hautarzt 1988; 39: 1–4. Markus Braun-Falco, Silke Stachowitz, Christina Schnopp, Johannes 3. Oranje AP, Wolkerstorfer A, de Waard-van der Spek FB. Treatment Ring and Dietrich Abeck of erythrodermic atopic dermatitis with ‘‘wet-wrap’’ uticasone Klinik und Poliklinik fu¨r Dermatologie und Allergologie am propionate 0,05% cream/emollient 1:1 dressing.
    [Show full text]
  • EPA's Guidance to Protect POTW Workers from Toxic and Reactive
    United States Office Of Water EPA 812-B-92-001 Environmental Protection (EN-336) NTIS No. PB92-173-236 Agency June 1992 EPA Guidance To Protect POTW Workers From Toxic And Reactive Gases And Vapors DISCLAIMER: This is a guidance document only. Compliance with these procedures cannot guarantee worker safety in all cases. Each POTW must assess whether measures more protective of worker health are necessary at each facility. Confined-spaceentry, worker right-to-know, and worker health and safety issues not directly related to toxic or reactive discharges to POTWs are beyond the scope of this guidance document and are not addressed. Additional copies of this document and other EPA documentsreferenced in this document can be obtained by writing to the National Technical Information Service (NTIS) at: 5285 Port Royal Rd. Springfield, VA 22161 Ph #: 703-487-4650 (NTIS charges a fee for each document.) FOREWORD In 1978, EPA promulgated the General Pretreatment Regulations [40 CFR Part 403] to control industrial discharges to POTWs that damage the collection system, interfere with treatment plant operations, limit sewage sludge disposal options, or pass through inadequately treated into receiving waters On July 24, 1990, EPA amended the General Pretreatment Regulations to respond to the findings and recommendations of the Report to Congress onthe Discharge of Hazardous Wastesto Publicly Owned Treatment Works (the “Domestic Sewage Study”), which identified ways to strengthen the control of hazardous wastes discharged to POTWs. The amendments add
    [Show full text]
  • 2U11/13U195 Al
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date Χ n n 20 October 2011 (20.10.2011) 2U11/13U195 Al (51) International Patent Classification: ka Pharmaceutical Co., Ltd., 1-7-1, Dosho-machi, Chuo- C12P 19/34 (2006.01) C07H 21/04 (2006.01) ku, Osaka-shi, Osaka 541-0045 (JP). (21) International Application Number: (74) Agents: KELLOGG, Rosemary et al; Swanson & PCT/US201 1/032017 Bratschun, L.L.C., 8210 SouthPark Terrace, Littleton, Colorado 80120 (US). (22) International Filing Date: 12 April 201 1 (12.04.201 1) (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, English (25) Filing Language: AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, (26) Publication Language: English CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (30) Priority Data: HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, 61/323,145 12 April 2010 (12.04.2010) US KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, (71) Applicants (for all designated States except US): SOMA- ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, LOGIC, INC. [US/US]; 2945 Wilderness Place, Boulder, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, Colorado 80301 (US). OTSUKA PHARMACEUTI¬ SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, CAL CO., LTD.
    [Show full text]
  • Treatment of Hyperhidrosis Dr
    “ Finding a solution to my sweating problem has With advanced technology and skilled hands, wholly changed my life. After having the Botox Matthew R. Kelleher, MD provides a full Premier Dermatology spectrum of services and procedures, including: for hyperhidrosis treatment, I am a thousand • Liposculpture times more confi dent and no longer afraid to • Botox, Juvéderm®, and Voluma™ Treatment TREATMENT OF lift my arms and be completely myself. I am so of Wrinkles thankful that this treatment exists!” • Laser Removal of Age Spots and Freckles HYPERHIDROSIS • Laser Facial Rejuvenation - Olivia • Laser Hair Removal Botox for hyperhidrosis patient • Laser Treatments of Rosacea, Facial Redness, and Spider Veins • Laser Scar Reduction • Laser Treatment of Stretch Marks “ Suffering from axillary hyperhidrosis, I thought • Laser Tattoo Removal • Laser Removal of Vascular Birthmarks there was nothing I could do. My condition • Laser and Photodynamic Treatment of Acne made me reluctant to participate in any social • Sclerotherapy for Leg Veins environment. Every day was a struggle until • Thermage® Radiofrequency Tissue Tightening liposuction for hyperhidrosis changed my life! • Microdermabrasion • Botox and Liposculpture Treatment of Hyperhidrosis Dr. Kelleher gave me the confi dence to feel • Sculpsure and Kybella for nonsurgical body sculpting comfortable in my own skin, and I never have to worry about embarrassing sweat stains again!” - Matthew Liposculpture for hyperhidrosis of the underarms patient “ After dealing with my excessive sweating for many years, without fully understanding it was a medical condition, Dr. Kelleher took the time to explain the treatment options available along with their results. I experienced immediate, positive results after my fi rst treatment which gave me a new sense of confi dence and removed the insurmountable stress I carried daily.
    [Show full text]
  • Material Safety Data Sheet Is for Carbon Dioxide Supplied in Cylinders with 33 Cubic Feet (935 Liters) Or Less Gas Capacity (DOT - 39 Cylinders)
    MATERIAL SAFETY DATA SHEET Prepared to U.S. OSHA, CMA, ANSI and Canadian WHMIS Standards 1. PRODUCT AND COMPANY INFORMATION CHEMICAL NAME; CLASS: CARBON DIOXIDE SYNONYMS: Carbon Anhydride, Carbonic Acid Gas, Carbonic Anhydride, Carbon Dioxide USP CHEMICAL FAMILY NAME: Acid Anhydride FORMULA: CO2 Document Number: 50007 Note: This Material Safety Data Sheet is for Carbon Dioxide supplied in cylinders with 33 cubic feet (935 liters) or less gas capacity (DOT - 39 cylinders). For Carbon Dioxide in large cylinders refer to Document Number 10039. PRODUCT USE: Calibration of Monitoring and Research Equipment MANUFACTURED/SUPPLIED FOR: ADDRESS: 821 Chesapeake Drive Cambridge, MD 21613 EMERGENCY PHONE: CHEMTREC: 1-800-424-9300 BUSINESS PHONE: 1-410-228-6400 General MSDS Information 1-713/868-0440 Fax on Demand: 1-800/231-1366 CARBON DIOXIDE - CO2 MSDS EFFECTIVE DATE: AUGUST 31, 2005 PAGE 1 OF 9 2. HAZARD IDENTIFICATION EMERGENCY OVERVIEW: Carbon Dioxide is a colorless, odorless, non-flammable gas. Over-exposure to Carbon Dioxide can increase respiration and heart rate, possibly resulting in circulatory insufficiency, which may lead to coma and death. At concentrations between 2-10%, Carbon Dioxide can cause nausea, dizziness, headache, mental confusion, increased blood pressure and respiratory rate. Exposure to Carbon Dioxide can also cause asphyxiation, through displacement of oxygen. If the gas concentration reaches 10% or more, suffocation can occur within minutes. Moisture in the air could lead to the formation of carbonic acid which can be irritating to the eyes. SYMPTOMS OF OVER-EXPOSURE BY ROUTE OF EXPOSURE: The most significant routes of over-exposure for this gas are by inhalation, and contact with the cryogenic liquid.
    [Show full text]